Ledger.Open graph →
SEC Form D · filed September 7, 2021

Bakx Therapeutics, Inc

Offering
$34.3M
Sold
$20.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BEARSVILLE, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Yibing Shan · Millburn, NJDirectorPhillippe Lopes-Fernandes · Boulonge-Billancourt, I0DirectorErvis Gavathiotis · Bearsville, NYExec · PromoterJessie English · Bearsville, NYExec · PromoterSree Kant · Bearsville, NYExec · Director · PromoterFrances Toneguzzo · Bearsville, NYPromoterLoren Walensky · Bearsville, NYExec · PromoterYibing Shan · Millburn, NJDirectorPhillippe Lopes-Fernandes · Boulonge-Billancourt, I0DirectorErvis Gavathiotis · Bearsville, NYExec · PromoterJessie English · Bearsville, NYExec · PromoterSree Kant · Bearsville, NYExec · Director · PromoterFrances Toneguzzo · Bearsville, NYPromoterLoren Walensky · Bearsville, NYExec · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗